Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 4/20 | 0.37 |
| ▸ | SLC22A12 | Q96S37 | 6/20 | 0.35 |
| ▸ | ITK | Q08881 | 2/20 | 0.34 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | SYK | P43405 | 2/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.32 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.32 |
| ▸ | GUCY1A1 | Q02108 | 1/20 | 0.32 |
| ▸ | GUCY1B1 | Q02153 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5054001 | 0.96 | KDM4C (0.36) | KDM4CSLC22A12ITKHASPINHTR7 | |
| SCHEMBL5055543 | 0.84 | KHK (0.38) | KDM4CSLC22A12ITKSYK | |
| SCHEMBL5055625 | 0.82 | CHEK1 (0.39) | KDM4CCHEK1 | |
| SCHEMBL5054165 | 0.82 | SYK (0.37) | KDM4CSLC22A12ITKSYKSCN9A | |
| SCHEMBL5053947 | 0.81 | SYK (0.36) | KDM4CSLC22A12SYKKDM4EALDH1A1 | |
| SCHEMBL5054031 | 0.80 | CHEK1 (0.44) | KDM4CSLC22A12ITKCHEK1ALDH1A1 | |
| SCHEMBL5055588 | 0.79 | CHEK1 (0.38) | KDM4CCHEK1 | |
| SCHEMBL28770040 | 0.71 | ITK (0.42) | ITK | |
| SCHEMBL5054000 | 0.71 | CHEK1 (0.46) | ITKCHEK1 | |
| SCHEMBL28770038 | 0.70 | ITK (0.45) | ITK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080004259-A1 | Inhibitors of Checkpoint Kinases | MERCK & CO., INC. | 2008-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080004259-A1 | Inhibitors of Checkpoint Kinases | CHEK1, CHEK2, BUB1B | KDM4C 974/4885SLC22A12 4472/4885ITK 493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.